Linkage of Meis1 leukemogenic activity to multiple downstream effectors including Trib2 and Ccl3.

[1]  C. Stocking,et al.  Acceleration of chronic myeloproliferation by enforced expression of Meis1 or Meis3 in Icsbp-deficient bone marrow cells , 2008, Oncogene.

[2]  M. Cleary,et al.  Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. , 2007, Genes & development.

[3]  R. Humphries,et al.  Hox genes in hematopoiesis and leukemogenesis , 2007, Oncogene.

[4]  C. Lavau,et al.  Flt3 is dispensable to the Hoxa9/Meis1 leukemogenic cooperation. , 2007, Blood.

[5]  E. Eklund,et al.  The role of HOX genes in malignant myeloid disease , 2007, Current opinion in hematology.

[6]  J. Aster,et al.  Tribbles Homolog 2 (Trib2) Inactivates C/EBPalpha and Causes Acute Myelogenous Leukemia. , 2006 .

[7]  Bas J. Wouters,et al.  Tribbles homolog 2 inactivates C/EBPalpha and causes acute myelogenous leukemia. , 2006, Cancer cell.

[8]  A. Wan,et al.  The Flt3 receptor tyrosine kinase collaborates with NUP98-HOX fusions in acute myeloid leukemia. , 2006, Blood.

[9]  J. Krosl,et al.  Molecular dissection of Meis1 reveals 2 domains required for leukemia induction and a key role for Hoxa gene activation. , 2006, Blood.

[10]  K. Sakamoto,et al.  FMS‐Like Tyrosine Kinase 3 in Normal Hematopoiesis and Acute Myeloid Leukemia , 2006, Stem cells.

[11]  G. Wang,et al.  Persistent Transactivation by Meis1 Replaces Hox Function in Myeloid Leukemogenesis Models: Evidence for Co-Occupancy of Meis1-Pbx and Hox-Pbx Complexes on Promoters of Leukemia-Associated Genes , 2006, Molecular and Cellular Biology.

[12]  R. Berger,et al.  NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogénétique Hématologique , 2006, Leukemia.

[13]  J. Hess,et al.  c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells. , 2005, Blood.

[14]  G. Wang,et al.  Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus. , 2005, Blood.

[15]  R. Humphries,et al.  Transplantable cell lines generated with NUP98–Hox fusion genes undergo leukemic progression by Meis1 independent of its binding to DNA , 2005, Leukemia.

[16]  He Huang,et al.  MEIS C Termini Harbor Transcriptional Activation Domains That Respond to Cell Signaling* , 2005, Journal of Biological Chemistry.

[17]  M. L. Le Beau,et al.  HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo. , 2005, Blood.

[18]  Pu Zhang,et al.  Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. , 2004, Immunity.

[19]  T. Uchiyama,et al.  Identification of differentially expressed molecules in adult T‐cell leukemia cells proliferating in vivo , 2004, Cancer science.

[20]  R. Humphries,et al.  Differential and Common Leukemogenic Potentials of Multiple NUP98-Hox Fusion Proteins Alone or with Meis1 , 2004, Molecular and Cellular Biology.

[21]  N. Copeland,et al.  Hematopoietic, angiogenic and eye defects in Meis1 mutant animals , 2004, The EMBO journal.

[22]  Purvesh Khatri,et al.  Onto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate , 2003, Nucleic Acids Res..

[23]  Ikuo Morita,et al.  Homeodomain proteins MEIS1 and PBXs regulate the lineage-specific transcription of the platelet factor 4 gene. , 2003, Blood.

[24]  C. Buske,et al.  Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1. , 2003, Blood.

[25]  N. Callander,et al.  AML-1A and AML-1B regulation of MIP-1α expression in multiple myeloma , 2003 .

[26]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[27]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[28]  David Eisenberg,et al.  Bioinformatic identification of potential autocrine signaling loops in cancers from gene expression profiles , 2001, Nature Genetics.

[29]  Torsten Haferlach,et al.  AML1–ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia , 2001, Nature Medicine.

[30]  Pu Zhang,et al.  Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia , 2001, Nature Genetics.

[31]  C. Croce,et al.  Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality , 2001, Oncogene.

[32]  U. Thorsteinsdóttir,et al.  NUP98–HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice , 2001, The EMBO journal.

[33]  Unnur Thorsteinsdottir,et al.  Defining Roles for HOX and MEIS1 Genes in Induction of Acute Myeloid Leukemia , 2001, Molecular and Cellular Biology.

[34]  N. Green,et al.  PBX and MEIS as Non-DNA-Binding Partners in Trimeric Complexes with HOX Proteins , 1999, Molecular and Cellular Biology.

[35]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[36]  Unnur Thorsteinsdottir,et al.  Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b , 1998, The EMBO journal.

[37]  J. Moskow,et al.  AbdB-like Hox proteins stabilize DNA binding by the Meis1 homeodomain proteins , 1997, Molecular and cellular biology.

[38]  K. Huebner,et al.  Meis1, a PBX1-related homeobox gene involved in myeloid leukemia in BXH-2 mice , 1995, Molecular and cellular biology.

[39]  H. Sul,et al.  Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation , 1993, Cell.

[40]  I. Pastan,et al.  Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. , 1986, Science.

[41]  W. Pear,et al.  Tribbles homolog 2 (Trib2) and HoxA9 cooperate to accelerate acute myelogenous leukemia. , 2008, Blood cells, molecules & diseases.

[42]  N. Callander,et al.  AML-1A and AML-1B regulation of MIP-1alpha expression in multiple myeloma. , 2003, Blood.

[43]  G. Behre,et al.  Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. , 2001, Nature genetics.

[44]  C. Figdor,et al.  Constitutive chemokine production results in activation of leukocyte function-associated antigen-1 on adult T-cell leukemia cells. , 1998, Blood.